Cardenas, Daniel – Trademark Portfolio
Entity Type: 01
Cardenas, Daniel owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as RUA, TRICAR, and TRANSITOW SCORPION. Of these, 3 are registered. The portfolio spans 9 Nice Classification classes, led by Class 40 (Treatment & Processing) and Class 37 (Building & Construction). Headquartered in Coral Gables, FL.
2665 SW 37th ave
Coral Gables, FL 33133
Showing of trademarks Trademarks
Trademark Classifications
Cardenas, Daniel's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Cardenas, Daniel have?
Cardenas, Daniel has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 1 cancelled.
What trademark classes does Cardenas, Daniel file in?
Cardenas, Daniel files trademarks across 9 Nice Classification classes. The most active classes are Class 40 (Treatment & Processing), Class 37 (Building & Construction), Class 35 (Advertising & Business), Class 31 (Natural Agricultural Products), Class 12 (Vehicles). Class 40 covers treatment of materials.
What are Cardenas, Daniel's most well-known trademarks?
Cardenas, Daniel's registered trademark portfolio includes well-known marks such as RUA, TRICAR, and TRANSITOW SCORPION. These are among 3 currently registered trademarks in the portfolio.
What is Cardenas, Daniel's trademark registration success rate?
Cardenas, Daniel has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.